Corrigendum to "Elevated frequencies of activated memory B cells in multiple sclerosis are reset to healthy control levels are B cell depletion with Ocrelizumab" [J. Neuroimmunol. 339:578502 (2024)]. J Neuroimmunol 2025 Feb 15;399:578519
Date
12/29/2024
Pubmed ID
39731832DOI
10.1016/j.jneuroim.2024.578519Scopus ID
2-s2.0-85213253349 (requires institutional sign-in at Scopus site)
Author List
Gurski CJ, Hajiyeva Z, Veltri AJ, Fenton K, O'Dell S, Obeidat AZ, Dittel BN
Author
Ahmed Zayed Obeidat MD, PhD Associate Professor in the Neurology department at Medical College of Wisconsin